Skip to content

Wearable MEG - Using novel technology to improve surgery outcome in epilepsy patients

Wearable MEG - Using novel technology to improve surgery outcome in epilepsy patients - OPMs for epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48086
Enrollment
7
Registered
2019-07-23
Start date
2020-12-03
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy seizure

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients have refractory epilepsy and are candidates for epilepsy surgery - We include adults (VUmc) or children of six years of age or older (UMCU). Adults: - Patients have already undergone a clinical SQUID-based MEG and dEEG at VUmc - 3 patients: confirmed focal source on dEEG of mesial temporal origin - 1 patient: frequent seizures (~daily);Children: - Six years of age or older - Patients have already undergone a clinical SQUID-based MEG with simultaneous scalp-EEG at VUmc - Confirmed focal source of epileptiform activity in clinical MEG or EEG

Exclusion criteria

Exclusion criteria: - Have already undergone surgery for their current epilepsy - The patients have already undergone a clinical SQUID-based MEG. Those patients who had claustrophobic or anxiety experiences from being enclosed in the magnetically shielded room will be excluded. - Patients with many artefacts, related to either movement or metal implants (not MEG compatible), on their clinical SQUID-based MEG

Design outcomes

Primary

MeasureTime frame
Primary outcome is a demonstration of the effectiveness of OPMs as a powerful diagnostic tool in epilepsy. The parameter we study is epileptiform activity (spikes, spike-waves). We will compare the even-rate (number of spikes/minute) and the strength (in terms of signal-to-noise ratio) between the different techniques.

Secondary

MeasureTime frame
Demonstration of the ability to successfully record MEG signals during a seizure.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)